TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (1S10OD024977-01)
  • Parker Institute for Cancer Immunotherapy